Titre : Euthanasie active

Euthanasie active : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Euthanasie active : Questions médicales les plus fréquentes", "headline": "Euthanasie active : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Euthanasie active : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-05", "dateModified": "2025-04-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Euthanasie active" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Euthanasie", "url": "https://questionsmedicales.fr/mesh/D005065", "about": { "@type": "MedicalCondition", "name": "Euthanasie", "code": { "@type": "MedicalCode", "code": "D005065", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N02.421.585.905.199" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Euthanasie active volontaire", "alternateName": "Euthanasia, Active, Voluntary", "url": "https://questionsmedicales.fr/mesh/D033101", "about": { "@type": "MedicalCondition", "name": "Euthanasie active volontaire", "code": { "@type": "MedicalCode", "code": "D033101", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N02.421.585.905.199.500.200" } } }, { "@type": "MedicalWebPage", "name": "Euthanasie animale", "alternateName": "Euthanasia, Animal", "url": "https://questionsmedicales.fr/mesh/D037901", "about": { "@type": "MedicalCondition", "name": "Euthanasie animale", "code": { "@type": "MedicalCode", "code": "D037901", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N02.421.585.905.199.500.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Euthanasie active", "alternateName": "Euthanasia, Active", "code": { "@type": "MedicalCode", "code": "D028601", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Marie E Nicolini", "url": "https://questionsmedicales.fr/author/Marie%20E%20Nicolini", "affiliation": { "@type": "Organization", "name": "Department of Bioethics, National Institutes of Health, Maryland, USA; and Center for Biomedical Ethics and Law, Katholieke Universiteit Leuven, Belgium." } }, { "@type": "Person", "name": "Scott Y H Kim", "url": "https://questionsmedicales.fr/author/Scott%20Y%20H%20Kim", "affiliation": { "@type": "Organization", "name": "Department of Bioethics, National Institutes of Health, Maryland, USA." } }, { "@type": "Person", "name": "Kathleen Cooney", "url": "https://questionsmedicales.fr/author/Kathleen%20Cooney", "affiliation": { "@type": "Organization", "name": "Education, Companion Animal Euthanasia Training Academy (CAETA), Loveland, CO, USA. Electronic address: cooneydvm@gmail.com." } }, { "@type": "Person", "name": "Beth Marchitelli", "url": "https://questionsmedicales.fr/author/Beth%20Marchitelli", "affiliation": { "@type": "Organization", "name": "4 Paws Farewell: Mobile Pet Hospice, Palliative Care and Home Euthanasia, Asheville, NC, USA." } }, { "@type": "Person", "name": "Jasper Doomen", "url": "https://questionsmedicales.fr/author/Jasper%20Doomen", "affiliation": { "@type": "Organization", "name": "Open University of the Netherlands, Faculty of Law, 6419 ATHeerlen, The Netherlands." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Communication about euthanasia in Dutch nursing homes.", "datePublished": "2024-04-25", "url": "https://questionsmedicales.fr/article/38662630", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/07481187.2024.2330011" } }, { "@type": "ScholarlyArticle", "name": "Assessment of thiamylal sodium as a euthanasia drug in mice.", "datePublished": "2024-03-29", "url": "https://questionsmedicales.fr/article/38556347", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1292/jvms.24-0041" } }, { "@type": "ScholarlyArticle", "name": "Factors associated with behavioral euthanasia in pet dogs.", "datePublished": "2024-04-17", "url": "https://questionsmedicales.fr/article/38746931", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fvets.2024.1387076" } }, { "@type": "ScholarlyArticle", "name": "Irremediability in psychiatric euthanasia: examining the objective standard.", "datePublished": "2022-10-28", "url": "https://questionsmedicales.fr/article/36305567", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1017/S0033291722002951" } }, { "@type": "ScholarlyArticle", "name": "The ephemeral self: The legitimacy of an advance euthanasia directive.", "datePublished": "2022-07-26", "url": "https://questionsmedicales.fr/article/35881502", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/00258024221107752" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Établissements, main d'oeuvre et services de soins de santé", "item": "https://questionsmedicales.fr/mesh/D005159" }, { "@type": "ListItem", "position": 3, "name": "Services de santé", "item": "https://questionsmedicales.fr/mesh/D006296" }, { "@type": "ListItem", "position": 4, "name": "Soins aux patients", "item": "https://questionsmedicales.fr/mesh/D005791" }, { "@type": "ListItem", "position": 5, "name": "Soins terminaux", "item": "https://questionsmedicales.fr/mesh/D013727" }, { "@type": "ListItem", "position": 6, "name": "Euthanasie", "item": "https://questionsmedicales.fr/mesh/D005065" }, { "@type": "ListItem", "position": 7, "name": "Euthanasie active", "item": "https://questionsmedicales.fr/mesh/D028601" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Euthanasie active - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Euthanasie active", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Euthanasie active", "description": "Comment diagnostiquer une souffrance insupportable ?\nQuels critères médicaux justifient l'euthanasie active ?\nComment évaluer le consentement du patient ?\nQuels examens sont nécessaires avant l'euthanasie ?\nQuelles sont les alternatives à l'euthanasie active ?", "url": "https://questionsmedicales.fr/mesh/D028601?page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Euthanasie active", "description": "Quels symptômes peuvent conduire à l'euthanasie active ?\nComment la souffrance psychologique se manifeste-t-elle ?\nQuels signes indiquent une souffrance physique extrême ?\nComment évaluer la qualité de vie d'un patient ?\nQuels symptômes psychologiques sont préoccupants ?", "url": "https://questionsmedicales.fr/mesh/D028601?page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Euthanasie active", "description": "Comment prévenir la souffrance insupportable ?\nQuels rôles jouent la communication et l'éducation ?\nComment impliquer la famille dans le processus ?\nQuels programmes de sensibilisation existent ?\nComment les lois influencent-elles la prévention ?", "url": "https://questionsmedicales.fr/mesh/D028601?page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Euthanasie active", "description": "Quels traitements peuvent être envisagés avant l'euthanasie ?\nComment les soins palliatifs aident-ils les patients ?\nQuels médicaments sont utilisés pour soulager la douleur ?\nComment le soutien psychologique est-il intégré ?\nQuels sont les risques des traitements palliatifs ?", "url": "https://questionsmedicales.fr/mesh/D028601?page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Euthanasie active", "description": "Quelles complications peuvent survenir lors de l'euthanasie ?\nComment gérer les complications psychologiques ?\nQuels sont les impacts sur la famille ?\nComment les professionnels gèrent-ils les dilemmes éthiques ?\nQuelles sont les conséquences légales de l'euthanasie ?", "url": "https://questionsmedicales.fr/mesh/D028601?page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Euthanasie active", "description": "Quels facteurs augmentent le risque de souffrance ?\nComment l'âge influence-t-il le risque ?\nQuel rôle joue l'accès aux soins de santé ?\nComment les antécédents médicaux influencent-ils le risque ?\nQuels facteurs socio-économiques sont impliqués ?", "url": "https://questionsmedicales.fr/mesh/D028601?page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une souffrance insupportable ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Évaluer la douleur, la qualité de vie et les avis médicaux pour déterminer l'irréversibilité." } }, { "@type": "Question", "name": "Quels critères médicaux justifient l'euthanasie active ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Critères incluent des maladies terminales, douleurs chroniques et absence d'espoir de guérison." } }, { "@type": "Question", "name": "Comment évaluer le consentement du patient ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Vérifier la capacité mentale du patient et s'assurer qu'il exprime un souhait éclairé." } }, { "@type": "Question", "name": "Quels examens sont nécessaires avant l'euthanasie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Examens cliniques, évaluations psychologiques et consultations médicales sont requis." } }, { "@type": "Question", "name": "Quelles sont les alternatives à l'euthanasie active ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les soins palliatifs et l'accompagnement psychologique sont des alternatives à considérer." } }, { "@type": "Question", "name": "Quels symptômes peuvent conduire à l'euthanasie active ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Douleurs intenses, souffrances psychologiques et perte de qualité de vie sont des symptômes clés." } }, { "@type": "Question", "name": "Comment la souffrance psychologique se manifeste-t-elle ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut se manifester par l'anxiété, la dépression et un sentiment d'angoisse face à la mort." } }, { "@type": "Question", "name": "Quels signes indiquent une souffrance physique extrême ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Signes incluent des douleurs persistantes, des crises fréquentes et une détérioration rapide." } }, { "@type": "Question", "name": "Comment évaluer la qualité de vie d'un patient ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des échelles de qualité de vie et des entretiens pour comprendre l'état du patient." } }, { "@type": "Question", "name": "Quels symptômes psychologiques sont préoccupants ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les pensées suicidaires, l'isolement social et la perte d'intérêt pour les activités sont alarmants." } }, { "@type": "Question", "name": "Comment prévenir la souffrance insupportable ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Assurer un suivi médical régulier et un accès à des soins palliatifs précoces peut aider." } }, { "@type": "Question", "name": "Quels rôles jouent la communication et l'éducation ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont essentielles pour informer les patients sur leurs options et les droits en matière de soins." } }, { "@type": "Question", "name": "Comment impliquer la famille dans le processus ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Encourager la discussion ouverte et le soutien familial peut réduire l'isolement du patient." } }, { "@type": "Question", "name": "Quels programmes de sensibilisation existent ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes éducatifs sur les soins palliatifs et l'euthanasie sont proposés par diverses organisations." } }, { "@type": "Question", "name": "Comment les lois influencent-elles la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les lois sur l'euthanasie et les soins palliatifs peuvent affecter l'accès aux traitements appropriés." } }, { "@type": "Question", "name": "Quels traitements peuvent être envisagés avant l'euthanasie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements palliatifs, la gestion de la douleur et le soutien psychologique sont essentiels." } }, { "@type": "Question", "name": "Comment les soins palliatifs aident-ils les patients ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils visent à soulager la douleur et à améliorer la qualité de vie sans chercher à prolonger la vie." } }, { "@type": "Question", "name": "Quels médicaments sont utilisés pour soulager la douleur ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les opioïdes et les analgésiques non opioïdes sont couramment utilisés pour la douleur intense." } }, { "@type": "Question", "name": "Comment le soutien psychologique est-il intégré ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il inclut des consultations avec des psychologues et des groupes de soutien pour le patient et la famille." } }, { "@type": "Question", "name": "Quels sont les risques des traitements palliatifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Risques incluent des effets secondaires des médicaments et une possible dépendance aux opioïdes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir lors de l'euthanasie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Complications incluent des réactions indésirables aux médicaments et des problèmes éthiques." } }, { "@type": "Question", "name": "Comment gérer les complications psychologiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi psychologique post-euthanasie est crucial pour la famille et le personnel médical." } }, { "@type": "Question", "name": "Quels sont les impacts sur la famille ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La famille peut éprouver des sentiments de culpabilité, de deuil et des conflits internes après l'euthanasie." } }, { "@type": "Question", "name": "Comment les professionnels gèrent-ils les dilemmes éthiques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Ils doivent suivre des protocoles éthiques et consulter des comités d'éthique pour des décisions difficiles." } }, { "@type": "Question", "name": "Quelles sont les conséquences légales de l'euthanasie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les conséquences varient selon les lois locales et peuvent inclure des poursuites judiciaires." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de souffrance ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les maladies chroniques, l'isolement social et le manque de soutien familial sont des facteurs de risque." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées sont souvent plus susceptibles de souffrir de maladies terminales et de douleurs chroniques." } }, { "@type": "Question", "name": "Quel rôle joue l'accès aux soins de santé ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un accès limité aux soins peut aggraver la souffrance et réduire les options de traitement." } }, { "@type": "Question", "name": "Comment les antécédents médicaux influencent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents de maladies graves ou de troubles mentaux peuvent augmenter le risque de souffrance." } }, { "@type": "Question", "name": "Quels facteurs socio-économiques sont impliqués ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "La pauvreté et le manque d'éducation peuvent limiter l'accès aux soins et augmenter la souffrance." } } ] } ] }

Sources (10000 au total)

Irremediability in psychiatric euthanasia: examining the objective standard.

Irremediability is a key requirement for euthanasia and assisted suicide for psychiatric disorders (psychiatric EAS). Countries like the Netherlands and Belgium ask clinicians to assess irremediabilit... Using treatment-resistant depression (TRD) as a test case, through a scoping review in PubMed, we analyzed the state-of-the-art evidence for whether clinicians can accurately predict individual long-t... A uniform definition of TRD is lacking, with over 150 existing definitions, mostly focused on psychopharmacological research. Available yet limited studies about long-term outcomes indicate that a maj... Our findings support the claim that, as per available evidence, clinicians cannot accurately predict long-term chances of recovery in a particular patient with TRD. This means that the objective stand...

Euthanasia in Africa: A scoping review of empirical evidence.

The core ethical perplexity is that physician-assisted suicide and euthanasia (PAS/E) contradicts the core value of medical practice which is about the duty of care to preserve life. While most argume... In this scoping review, a systematic search of five electronic research databases-PubMed, SCOPUS, CINHAL Complete, Allied and Complementary Medicine (AMED), and APA PsycInfo-was conducted to identify ... Only 14 articles reporting empirical studies, conducted in Africa, and published in English, were included in the review after a rigorous screening process. The review shows a wide rejection of euthan... Euthanasia will continue to be a subject of controversy and debate in Africa and elsewhere. The majority of Africans hold the duty of care and preservation of life as the hallmark of medical practice,...

Kidney Transplant Outcome Following Donation After Euthanasia.

In the Netherlands, organ donation after euthanasia (donation after circulatory death type V [DCD-V]) has been increasingly performed since 2012. However, the outcomes of DCD-V kidney grafts have not ... To investigate the outcomes of DCD-V kidney transplantation and compare them with outcomes of kidney transplantation after circulatory death after withdrawal of life-sustaining therapies (DCD type III... A retrospective cohort study was conducted using the database from the Dutch Transplant Foundation. All kidney transplants in the Netherlands between January 2012 (start of the euthanasia program) and... Kidney transplantation with a DCD-V graft compared with DCD-III and DBD grafts.... The primary outcome was death-censored graft survival until 5 years after transplantation. Secondary outcomes were the incidence of delayed graft function (DGF), permanent nonfunction (PNF), serum cre... A total of 145 DCD-V kidney transplants were compared with 1936 DCD-III and 1255 DBD kidney transplants. Median (IQR) recipient age was 59 (46-66) years in the DCD-V cohort, compared with 61 (50-68) y... This study found that DCD-V kidney transplantation yielded a lower incidence of DGF compared with DCD-III kidney transplantation and yielded long-term results similar to those of DCD-III and DBD kidne...